Vagus nerve stimulation (VNS): Clinical trials have shown that VNS reduces depressive symptoms in treatment-resistant depression while modulating systemic inflammation, with documented reductions in TNF-α and IL-6 levels [69]. This evidence concerns the gene IL6 and major depressive disorder.